| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
|
J Neurooncol
|
2007
|
1.47
|
|
2
|
Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
|
Biochem Pharmacol
|
2004
|
1.04
|
|
3
|
Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.
|
J Exp Ther Oncol
|
2005
|
0.99
|
|
4
|
Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.
|
Anticancer Res
|
2010
|
0.95
|
|
5
|
Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.
|
Anticancer Res
|
2011
|
0.93
|
|
6
|
Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells.
|
Biochem Biophys Res Commun
|
2011
|
0.90
|
|
7
|
ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells.
|
Anticancer Res
|
2013
|
0.87
|
|
8
|
Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer.
|
Cancers (Basel)
|
2011
|
0.86
|
|
9
|
Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects.
|
Biochem Pharmacol
|
2003
|
0.86
|
|
10
|
Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB.
|
Immunopharmacol Immunotoxicol
|
2009
|
0.82
|
|
11
|
Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer.
|
Molecules
|
2012
|
0.81
|
|
12
|
Immunomodulatory activity of synthetic triterpenoids: inhibition of lymphocyte proliferation, cell-mediated cytotoxicity, and cytokine gene expression through suppression of NF-kappaB.
|
Immunopharmacol Immunotoxicol
|
2008
|
0.80
|
|
13
|
Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.
|
J Exp Ther Oncol
|
2014
|
0.80
|
|
14
|
Role of reactive oxygen species (ROS) in CDDO-Me-mediated growth inhibition and apoptosis in colorectal cancer cells.
|
J Exp Ther Oncol
|
2011
|
0.79
|
|
15
|
Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.
|
Oncol Res
|
2008
|
0.79
|
|
16
|
Role of telomerase in anticancer activity of pristimerin in prostate cancer cells.
|
J Exp Ther Oncol
|
2015
|
0.78
|
|
17
|
Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.
|
J Exp Ther Oncol
|
2012
|
0.78
|
|
18
|
MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP).
|
BMC Med Imaging
|
2011
|
0.75
|
|
19
|
Bone marrow-derived stromal cells (BMSCs) interact with fibroblasts in accelerating wound healing.
|
J Invest Surg
|
2009
|
0.75
|
|
20
|
In vitro analysis of the antileukemic effect of tumor necrosis factor-alpha gene therapy with myeloid progenitor cells: the role of dendritic cells.
|
J Exp Ther Oncol
|
2003
|
0.75
|